Open AccessImmune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study
Author(s) -
Ana Ascaso,
Javier García-Pérez,
Mayte PérezOlmeda,
Eunate AranaArri,
Itziar Vergara,
Carla Pérez-Ingidua,
Mercedes Bermejo,
María Castillo de la Osa,
Natale Imaz-Ayo,
Ioana Riaño Fernández,
Oliver Astasio González,
Francisco Díez-Fuertes,
Susana Meijide,
Julio Arrizabalaga,
Lourdes Hernández Gutiérrez,
Humberto Erick de la Torre-Tarazona,
Alberto Lázaro,
Emilio Vargas Castrillón,
José Alcamí,
Antonio Portolés
Publication year - 2022
Publication title -
eclinicalmedicine
Language(s) - English
Resource type - Journals
ISSN - 2589-5370
DOI - 10.1016/j.eclinm.2022.101542
Subject(s) - reactogenicity , medicine , vaccination , immunogenicity , myalgia , cohort , adverse effect , pediatrics , immunology , antibody